FIGURE 2.

Proposed flowcharts for the consideration of initiating hormonal contraceptive therapy or hormone replacement therapy (A), and for the approach to the patient who develops a venous thromboembolic event while on the aforementioned therapy (B). *Risk factor for consideration but should undergo risk/benefit discussion with the patient †Expert advice may be needed to determine factors. Abbreviations: BMI, body mass index; COC, combined oral contraceptive; HRT, hormone replacement therapy; LNG IUD, levonorgestrel intrauterine device; VTE, venous thromboembolism